Novo Nordisk A/S – Articles of Association
Novo Nordisk's Articles of Association 2022 after capital reduction, 27 April 2022 Attachment NN_Articles_of_Association_2022_After CapReduction
Staff
Novo Nordisk A/S – Reduction of the share capital
Bagsværd, Denmark, 27 April 2022 – At Novo Nordisk’s Annual General Meeting on 24 March 2022, it was decided to...
Codex DNA Unveils Automated Synthetic Biology Solutions for Antibody and Protein Engineering of Biotherapeutic Targets at 18th Annual PEGS Boston Conference and Expo
BioXp™ system and RapidAMP™ cell-free DNA kit allow scientists to synthesize, clone, and amplify antibody-variable regions based on a digital...
iCAD to Report First Quarter 2022 Financial Results on Wednesday, May 11
NASHUA, N.H., April 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection...
AcelRx Hosting Key Opinion Leader Webinar on Niyad™ Nafamostat Program
Key Opinion Leaders participating will be Stuart Goldstein, MD, Cincinnati Children’s Hospital and Lakhmir Chawla, MD, former Chief of the Division...
Volta Medical VX1 AI Software to be Featured at Heart Rhythm 2022
- Company’s VX1 AI software for use in atrial fibrillation will be featured during several events at the Congress -...
Comprehensive Analysis in Frontiers in Neuroscience Highlights Acumen Pharmaceuticals’ New Approach to Treating Alzheimer’s Disease
Acumen focused on developing investigational monoclonal antibody targeting amyloid beta oligomersCHARLOTTESVILLE, Va. and CARMEL, Ind., April 27, 2022 (GLOBE NEWSWIRE)...
Allogene Therapeutics Receives FDA Orphan-Drug Designation for ALLO-605, its First TurboCAR™ T Cell Product Candidate, for the Treatment of Multiple Myeloma
ODD Follows FDA Fast Track Designation Granted for ALLO-605 in Q2 2021ALLO-605 is in Phase 1 in the IGNITE Trial...
Shockwave Medical Announces Details for Conference Call Discussing First Quarter 2022 Results and Participation in Upcoming Investor Conferences
SANTA CLARA, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of...
Tempest Announces Private Placement Financing of $15 Million
SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing...
BrainsWay to Report First Quarter Financial Results on May 11, 2022
BURLINGTON, Mass. and JERUSALEM, April 27, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
Inspire Medical Systems, Inc. to Present at the BofA Securities 2022 Healthcare Conference
MINNEAPOLIS, April 27, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
Caladrius Biosciences and Cend Therapeutics Announce Definitive Merger Agreement
Combined company to be renamed Lisata Therapeutics upon transaction closing Combination will create a financially sound Nasdaq-listed company with a...
Erasca Appoints Jean Liu to its Board of Directors
Ms. Liu, currently chief legal officer at Seagen, brings decades of business and legal experience and will also join Erasca’s...
Oyster Point Pharma to Present New Analyses at the Association for Research in Vision and Ophthalmology (ARVO) 2022
PRINCETON, N.J., April 27, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a commercial-stage biopharmaceutical company focused on...
GBT to Announce First Quarter 2022 Financial Results on Wednesday, May 4, 2022
SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it...
Simply Better Brands Corp. Announces Execution of Non-Binding Term Sheet to Acquire CFH Limited, a Seed-To-Shelf CBD Manufacturer, to Support Accelerated Growth
Acquisition enables expanded vertical integration, research-driven innovation and cost synergies on the PureKana Wellness BrandVANCOUVER, British Columbia, April 27, 2022...
ContraFect Data Presentations at the 32nd Annual ECCMID Meeting Highlight the Potential of Engineered Lysin CF-370 to Improve Clinical Outcomes and Suppress Antimicrobial Resistance Compared to Antibiotics Alone
Oral Session Demonstrates CF-370’s Potent Activity in a Rabbit Pneumonia Model of an Extensively-Resistant Pseudomonas aeruginosa InfectionYONKERS, N.Y., April 27,...
InnerScope Hearing Technologies (OTC: INND) Launches New eCommerce Website with the Rebranding of iHEAR Direct-to-Consumer Hearing Aids
The New Relaunch of iHEARdirect.com Website Includes: Enhanced Customer FeaturesFree Online Hearing ScreeningHearing Aid & Hearing Loss Information BlogSeries of...
Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern Time
RALEIGH, N.C., April 27, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers...
